Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
Clinical trial NCT00205842 · COMPLETED
Trial details
- NCT number
- NCT00205842
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2005-12-01
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.